首页 | 本学科首页   官方微博 | 高级检索  
   检索      


From NMDA receptor antagonists to discovery of selective σ2 receptor ligands
Institution:1. H&I Laboratory, NHSBT Birmingham Centre, Vincent Drive, Edgbaston, Birmingham B15 2SG, UK;2. Department of Nephrology and Kidney Transplantation, Queen Elizabeth Hospital Birmingham, B15 2WB, UK;3. Department of Liver Transplantation, Queen Elizabeth Hospital Birmingham, B15 2WB, UK;4. Department of Hepatology and Liver Transplantation, Queen Elizabeth Hospital Birmingham, B15 2WB, UK;5. Department of Kidney Transplantation, Queen Elizabeth Hospital Birmingham, B15 2WB, UK;6. Department of Pathology, Queen Elizabeth Hospital Birmingham, B15 2WB, UK;1. 1 Laboratoire SUBATECH, CNRS/IN2P3-EMN-Université, 4 rue Alfred Kastler, 44307 Nantes, France;2. GIP Arronax, 1 rue Aronnax, 44817 Saint-Herblain, France
Abstract:Following previous studies focused on the search for new molecules targeting GluN2B-containing NMDA, a small series of 1-(1H-indol-3-yl)-2-(4-phenylpiperidin-1-yl)ethanone derivatives has been synthesized by using Microwave Assisted Organic Synthesis (MAOS). Given that GluN2B ligands frequently exert off-target effects we also tested their affinity towards sigma receptors. Binding assay revealed that only the 1-(5-hydroxy-1H-indol-3-yl)-2-(4-phenylpiperidin-1-yl)ethanone (7a) retained GluN2B affinity. Interestingly, the 5-methoxyindoles 5a and 6a were efficient and selective ligands toward σ2 receptor (Ki values of 10 nM and 20 nM, respectively). Thus, in this case the discovery of new σ2 receptor selective ligands was an unexpected result emerging from the screening of cross-activity against other CNS receptors.
Keywords:Glutamate  GluN2B/NMDA  Sigma receptor  Indoles  Ifenprodil
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号